Dihydrolipoamide dehydrogenase (DLD) is a novel molecular target of bortezomib.
Feng Y, Luo H, Huang J, Zhang Y, Wen J, Li L, Mi Z, Gao Q, He S, Liu X, Zhai X, Wang X, Zhang L, Niu T, Zheng Y.
Feng Y, et al. Among authors: huang j.
Cell Death Dis. 2024 Aug 13;15(8):588. doi: 10.1038/s41419-024-06982-2.
Cell Death Dis. 2024.
PMID: 39138149